A patient with type 2 diabetes has new diagnostic results indicating early-stage nephropathy, dyslipidemia, mild to moderate diabetic neuropathy, and early signs of diabetic retinopathy. Which intervention should the nurse prioritize to address the patient's current health status and prevent further complications?

D) Educate on dietary modifications to improve lipid profile and glycemic control.

A) Initiate a diabetic foot care program to prevent neuropathic ulcers.

B) Recommend the addition of an SGLT2 inhibitor to the medication regimen.

C) Advise scheduling regular ophthalmological exams every six months.

D) Educate on dietary modifications to improve lipid profile and glycemic control.

A patient with a history of type 2 diabetes and hypertension presents with increased ankle edema, fluctuating blood glucose levels, and a recent rise in serum creatinine. Which nursing intervention is most appropriate to address the patient's current condition?

B) Educate the patient about the importance of adhering to a low-sodium diet.

A) Encourage the patient to decrease fluid intake to reduce edema.

B) Educate the patient about the importance of adhering to a low-sodium diet.

C) Suggest the patient increases their carbohydrate intake to stabilize blood glucose levels.

D) Recommend the patient discontinue the use of antihypertensive medication until symptoms improve.

A patient with diabetes and hypertension presents with persistent fatigue, dizziness, increased urination, and ankle edema. Lab results show hemoglobin A1c of 8.5%, serum sodium of 134 mmol/L, and eGFR of 58 mL/min/1.73 m². Which nursing intervention is most appropriate to prioritize based on these findings?

C) Monitor the patient for signs of orthostatic hypotension.

A) Educate the patient on the importance of adhering to a low-sodium diet.

B) Assess the patient’s understanding and technique of blood glucose monitoring.

C) Monitor the patient for signs of orthostatic hypotension.

D) Encourage increased fluid intake to manage serum sodium levels.

A patient with type 2 diabetes and renal impairment presents with persistent fluid retention, occasional shortness of breath on exertion, and a rising serum creatinine level. Which nursing intervention should be prioritized to address the patient's current symptoms and potential complications?

A) Educate the patient on the importance of a low-sodium diet to manage fluid retention.

B) Encourage the patient to increase fluid intake to promote renal function.

C) Monitor the patient's blood glucose levels more frequently to achieve better glycemic control.

D) Recommend the patient engage in daily vigorous exercise to improve cardiovascular health.

A patient with type 2 diabetes and chronic kidney disease is experiencing increased urination, occasional shortness of breath, and ankle edema. Recent lab results show a hemoglobin A1c of 8.2%, serum creatinine of 1.8 mg/dL, and an eGFR of 54 mL/min/1.73 m². Which intervention should the nurse expect to be prioritized in the updated treatment plan to address these findings?

A) Increase the dose of the GLP-1 receptor agonist

A patient with type 2 diabetes and early signs of heart failure is experiencing increased serum creatinine levels and a decline in eGFR. Which nursing intervention is most appropriate to address the patient's fluid overload and prevent further renal impairment?

B) Monitor daily weight and educate the patient on reporting significant changes.

A) Encourage increased fluid intake to promote renal function.

B) Monitor daily weight and educate the patient on reporting significant changes.

C) Advise the patient to avoid all physical activity to reduce cardiac stress.

D) Increase dietary potassium intake to offset diuretic effects.

A patient with a history of diabetes and early signs of heart failure reports increased palpitations and a persistent cough that worsens when lying down. Considering the patient's current condition and treatment plan, which nursing intervention is most appropriate to prioritize at this time?

B) Encourage the patient to perform daily weight monitoring and report any rapid increases.

A) Educate the patient on the importance of maintaining a low-sodium diet to manage fluid retention.

B) Encourage the patient to perform daily weight monitoring and report any rapid increases.

C) Focus on reinforcing the importance of consistent glycemic control to prevent further complications.

D) Advise the patient to monitor and record episodes of palpitations and report them to the healthcare provider.

A patient on diuretic therapy and SGLT2 inhibitors reports increased fatigue and dizziness, especially upon standing. Vital signs show a blood pressure of 122/78 mmHg and a heart rate of 88 bpm. What is the most appropriate nursing action to address the patient's symptoms?

B) Educate the patient on slowly changing positions to reduce dizziness.

A) Advise the patient to increase fluid intake to prevent dehydration.

B) Educate the patient on slowly changing positions to reduce dizziness.

C) Recommend the patient to take diuretics at bedtime to minimize symptoms.

D) Suggest reducing physical activity to avoid exacerbating fatigue.

A patient with heart failure and type 2 diabetes has been experiencing increased fatigue and dizziness upon standing after starting a diuretic and adjusting an SGLT2 inhibitor. Which nursing intervention is most appropriate to address the patient's reported symptoms while considering the patient's current condition?

B) Educate the patient to rise slowly from sitting or lying positions to prevent dizziness.

A) Advise the patient to increase fluid intake to counteract dehydration.

B) Educate the patient to rise slowly from sitting or lying positions to prevent dizziness.

C) Recommend reducing the dosage of the diuretic to alleviate fatigue.

D) Suggest the patient to consume more carbohydrates to improve energy levels.

Diabetes - Nursing Case Study

Pathophysiology

• Primary mechanism: Insulin resistance - In type 2 diabetes, body cells become less responsive to insulin, leading to decreased glucose uptake and increased blood sugar levels. This resistance is often due to obesity, sedentary lifestyle, and genetic factors.

• Secondary mechanism: Beta-cell dysfunction - Over time, the pancreatic beta cells become unable to produce sufficient insulin to overcome the resistance, further exacerbating hyperglycemia. Chronic high blood sugar and fatty acids can damage these cells, worsening the cycle.

• Key complication: Hyperglycemia-induced damage - Persistent high blood sugar levels can lead to vascular complications such as neuropathy, retinopathy, and nephropathy, significantly impacting patient quality of life and increasing the risk of cardiovascular diseases.

Patient Profile

Demographics:

58-year-old male, accountant

History:

• Key past medical history: Type 2 Diabetes diagnosed 8 years ago, hypertension, dyslipidemia

• Current medications: Metformin 1000 mg twice daily, Lisinopril 20 mg once daily, Atorvastatin 10 mg once daily, Aspirin 81 mg once daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing numbness and tingling in feet

• Key symptoms: Fatigue, frequent urination, blurred vision, occasional dizziness

• Vital signs: Blood pressure 145/90 mmHg, heart rate 88 bpm, respiratory rate 18 breaths/min, temperature 98.6°F, blood glucose 210 mg/dL

Section 1

New Diagnostic Results:

Following the initial presentation, the healthcare team decides to conduct further diagnostic tests to better understand the extent of the patient's diabetic complications and to refine the management plan. A comprehensive metabolic panel reveals a slightly elevated serum creatinine level of 1.5 mg/dL, indicating potential early-stage nephropathy, a common complication of diabetes. The estimated glomerular filtration rate (eGFR) is calculated at 60 mL/min/1.73 m², suggesting mild renal impairment. Additionally, a lipid panel shows total cholesterol of 210 mg/dL, LDL cholesterol of 140 mg/dL, HDL cholesterol of 35 mg/dL, and triglycerides at 180 mg/dL, reflecting suboptimal control of dyslipidemia, which poses an added risk for cardiovascular disease.

A nerve conduction study is performed to evaluate the extent of peripheral neuropathy, given the patient's chief complaint of numbness and tingling in his feet. The results confirm mild to moderate sensory neuropathy, consistent with diabetic neuropathy, which is further corroborated by reduced vibration sense and diminished ankle reflexes on physical examination. An ophthalmological exam is also carried out, revealing early signs of diabetic retinopathy, including microaneurysms and mild non-proliferative changes, underscoring the need for tighter glycemic control and regular eye examinations.

These findings prompt a multidisciplinary approach to adjust the patient's treatment regimen. The healthcare team emphasizes the importance of lifestyle modifications, including dietary changes and increased physical activity, to improve blood sugar and lipid levels. Consideration is given to modifying the patient's medication regimen, potentially adding a sodium-glucose co-transporter-2 (SGLT2) inhibitor or a glucagon-like peptide-1 (GLP-1) receptor agonist to enhance glycemic control and provide renal protective benefits. The patient's journey now focuses on addressing these complications proactively to prevent further deterioration and improve overall health outcomes.

Section 2

Change in Patient Status:

Several weeks into the revised management plan, the patient returns for a follow-up visit. During this appointment, the patient reports persistent fatigue, occasional dizziness, and an increased frequency of urination, which raises concerns for the healthcare team. A physical examination reveals a blood pressure of 150/90 mmHg, which is higher than previous readings, indicating suboptimal control of hypertension. The patient's weight remains stable, but there is a noted increase in ankle edema, suggesting possible fluid retention. Fingerstick blood glucose readings from the patient's logbook show fluctuating values, with several readings exceeding 200 mg/dL, underscoring the need for further intervention to achieve better glycemic control.

Repeat laboratory tests provide additional insight into these symptoms. The hemoglobin A1c level is measured at 8.5%, showing inadequate long-term glycemic control and confirming the need for more aggressive diabetes management. Serum sodium is slightly reduced at 134 mmol/L, raising suspicions of hyponatremia possibly due to the side effects of current medications or changes in dietary habits. The patient's serum creatinine has risen slightly to 1.6 mg/dL, and the eGFR has decreased to 58 mL/min/1.73 m², suggesting a slow progression of diabetic nephropathy. Lipid levels show minor improvement, with LDL cholesterol reduced to 130 mg/dL, though still not at target levels.

These findings prompt the healthcare team to intensify the treatment plan. Adjustments are made to the patient's antihypertensive regimen, with the addition of an angiotensin receptor blocker (ARB) to address both hypertension and nephropathy. The diabetes management strategy is also revised, with the initiation of a GLP-1 receptor agonist to improve glycemic control and potentially assist with weight management. The patient is encouraged to maintain a low-sodium diet and is referred to a dietitian for personalized dietary advice. This change in the patient's status highlights the need for ongoing monitoring and collaborative care to address the complexities of diabetes management, setting the stage for the next phase of treatment evaluation.

Section 3

Several weeks after the intensified treatment plan was implemented, the patient returns for another follow-up appointment. The healthcare team is eager to assess the patient's response to the new interventions. During this visit, the patient reports a slight improvement in fatigue levels and a reduction in the frequency of dizziness. However, the increased urination persists, and the patient now complains of occasional shortness of breath, particularly during physical activity. A physical examination reveals a blood pressure of 145/88 mmHg, showing marginal improvement, yet still not reaching target levels. The ankle edema remains present, but there is no significant increase.

Laboratory tests are repeated to evaluate the patient's progress. The hemoglobin A1c level has decreased to 8.2%, indicating some improvement in glycemic control, though it remains above the desired target. Serum sodium has stabilized at 135 mmol/L, suggesting a more balanced electrolyte status, possibly due to dietary modifications and medication adjustments. However, the serum creatinine has risen slightly again to 1.8 mg/dL, and the eGFR has declined to 54 mL/min/1.73 m², hinting at a continued progression of renal impairment despite current interventions. Lipid profile results show LDL cholesterol at 125 mg/dL, reflecting modest progress in lipid management.

These findings prompt the healthcare team to undertake further modifications to the treatment strategy. The persistence of fluid retention and the new symptom of dyspnea raise concerns about potential heart failure, necessitating a cardiology consult to explore the possibility of diabetic cardiomyopathy. The diabetes management plan is further adjusted by increasing the dose of the GLP-1 receptor agonist and considering the addition of an SGLT2 inhibitor to enhance renal protection and cardiovascular health. The patient is advised to monitor symptoms closely and to report any worsening immediately. This scenario highlights the dynamic nature of diabetes management, requiring continuous reassessment and adaptation to effectively manage emerging complications.

Section 4

Two weeks following the modification of the treatment plan, the patient returns for another follow-up appointment. During this visit, the patient reports a slight improvement in breathlessness, particularly noting less shortness of breath during mild physical activities such as walking short distances. However, they now experience occasional palpitations, leading to increased anxiety about their health status. The patient also mentions a mild but persistent cough that worsens when lying down, raising further concerns about potential cardiac involvement.

Upon examination, the patient's vital signs reveal a blood pressure of 140/86 mmHg, showing a marginal improvement, and a heart rate of 96 beats per minute, slightly elevated from previous visits. The ankle edema remains unchanged, and lung auscultation reveals mild bilateral crackles at the lung bases, suggesting possible fluid overload. An ECG performed in the clinic shows occasional premature ventricular contractions, prompting further investigation into the patient's cardiac status.

Laboratory results indicate a stable hemoglobin A1c at 8.1%, reflecting consistent glycemic control. However, the serum creatinine has increased to 2.0 mg/dL, and the eGFR has further declined to 50 mL/min/1.73 m², indicating progressive renal impairment. The cardiology consult confirms early signs of heart failure, likely exacerbated by fluid retention and the underlying diabetic condition. In response, the healthcare team initiates a low-dose diuretic to manage fluid overload and considers adjusting the SGLT2 inhibitor to support both renal and cardiac function. The patient is advised to maintain a low-sodium diet and to monitor weight daily, as a rapid increase could suggest worsening heart failure. This situation emphasizes the need for a multidisciplinary approach in managing complex diabetes cases with evolving complications.

Section 5

In the weeks following the initiation of the diuretic and the adjustment of the SGLT2 inhibitor, the patient returns for a follow-up visit, noting some positive changes. The patient reports a reduction in ankle edema and a noticeable decrease in breathlessness, particularly when lying down, suggesting an improvement in fluid management. However, they express concern about increased fatigue and occasional dizziness, especially upon standing, which could be indicative of potential orthostatic hypotension as a side effect of the diuretic therapy.

During the clinical examination, the patient's vital signs reveal a blood pressure of 122/78 mmHg, indicating a significant improvement but also raising suspicion of potential hypotension given the reported symptoms. The heart rate is 88 beats per minute, showing slight improvement. Lung auscultation identifies a reduction in crackles, correlating with the decreased fluid overload. However, a repeat ECG demonstrates more frequent premature ventricular contractions compared to the previous visit, necessitating further cardiac evaluation.

Laboratory tests reveal that the serum creatinine has stabilized at 1.9 mg/dL, and the eGFR remains at 52 mL/min/1.73 m², suggesting a slight improvement in renal function likely due to better fluid management. Despite these improvements, the patient's hemoglobin A1c remains unchanged at 8.1%, indicating the need for further optimization of glycemic control. The healthcare team decides to consult with a cardiologist to assess the need for additional cardiac interventions and to consider potential adjustments to the current diabetes management plan to address the persistent hyperglycemia. This evolving scenario underscores the necessity of closely monitoring the patient's response to interventions and the importance of ongoing collaboration among healthcare providers to mitigate the risks of new complications.